Announcement on Change of Drug Production License
Filed with SSE · · 3 pages · Chinese
Tianjin Tianyao Pharmaceuticals Co., Ltd. on 6ix
Earlier from Tianjin Tianyao Pharmaceuticals
- Announcement on Receiving Results of GMP Compliance Inspection Concerning Drugs
- Announcement on Resolutions of the 19th Meeting of the 9th Board of Directors
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
- Semi-annual Earnings Preannouncement for 2025
- Announcement on Subsidiary's Drug Passing Generic Drug Consistency Evaluation
Later from Tianjin Tianyao Pharmaceuticals
- Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
- 2025 Semi-annual Report
- Announcement on the Company's Receipt of the Notice of Approval for Marketing Application of Chemical APIs
- Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Tianjin Jurisdiction
- Announcement on Convening the Q3 2025 Performance Briefing
Follow Tianjin Tianyao Pharmaceuticals into a list and get an email when it puts out news.
Follow Tianjin Tianyao Pharmaceuticals